Sanofi sues Merck for infringement of multiple patents in US
Release time:
2016-09-21 02:04
Nanjing China News: Sanofi said in a lawsuit filed in the U.S. Federal District Court of Delaware that Merck Sharp & Dohme Corp. It infringed on as many as 10 patents held by Sanofi, including its hot-selling diabetes drug Lantus and insulin injection pen soloSTAR.
Sanofi said it had initiated legal action against Merck. Merck previously filed a new drug application with the Food and Drug Administration.
Paris-based Sanofi is one of the world's largest makers of diabetes drugs, but parts of its business are under pressure from an increasingly cost-conscious health care system. As competition among insulin manufacturers intensifies, Sanofi expects revenue from diabetes drugs to decline in the coming years.
Room 409, Building 23, Zhongke Innovation Plaza, No. 150 Pubin Road, Jiangbei New District, Nanjing, Jiangsu Province
Copyright ◎ Nanjing Huaxun Intellectual Property Consultants Co., Ltd.